Scolr Pharma said this week that it has appointed Greg Weaver to its board of directors.
Weaver is currently CFO of Talyst, a provider of automated pharmacy solutions. He was previously CFO of Sirna Therapeutics.
Nastech Pharmaceutical said last week that it has promoted Henry Costantino to CSO of delivery, following the resignation of former CSO Paul Johnson.
Costantino previously served as director of formulations at Nastech and was recently promoted to vice president of pharmaceutical research and development. Before Nastech, he worked at Alkermes and Genentech.
He holds BS and MS degrees from Johns Hopkins University, and a PhD in chemical engineering from the Massachusetts Institute of Technology.